Genelux Statistics
Share Statistics
Genelux has 37.73M
shares outstanding. The number of shares has increased by 9.83%
in one year.
| Shares Outstanding | 37.73M |
| Shares Change (YoY) | 9.83% |
| Shares Change (QoQ) | 9.24% |
| Owned by Institutions (%) | 14.76% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 10,858 |
| FTD / Avg. Volume | 5.36% |
Short Selling Information
The latest short interest is 2.3M, so 6.12% of the outstanding
shares have been sold short.
| Short Interest | 2.3M |
| Short % of Shares Out | 6.12% |
| Short % of Float | 7.15% |
| Short Ratio (days to cover) | 9.3 |
Valuation Ratios
The PE ratio is -2.48 and the forward
PE ratio is -2.34.
Genelux's PEG ratio is
0.14.
| PE Ratio | -2.48 |
| Forward PE | -2.34 |
| PS Ratio | 9277.96 |
| Forward PS | 0.5 |
| PB Ratio | 2.82 |
| P/FCF Ratio | -3.43 |
| PEG Ratio | 0.14 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Genelux.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.57,
with a Debt / Equity ratio of 0.07.
| Current Ratio | 4.57 |
| Quick Ratio | 4.57 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | -0.06 |
| Debt / FCF | -0.09 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $333.33 |
| Profits Per Employee | $-1,244,541.67 |
| Employee Count | 24 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -30.46% in the
last 52 weeks. The beta is -0.4, so Genelux's
price volatility has been lower than the market average.
| Beta | -0.4 |
| 52-Week Price Change | -30.46% |
| 50-Day Moving Average | 3.29 |
| 200-Day Moving Average | 2.86 |
| Relative Strength Index (RSI) | 38.76 |
| Average Volume (20 Days) | 202,578 |
Income Statement
In the last 12 months, Genelux had revenue of 8K
and earned -29.87M
in profits. Earnings per share was -0.95.
| Revenue | 8K |
| Gross Profit | 8K |
| Operating Income | -31.7M |
| Net Income | -29.87M |
| EBITDA | -28.97M |
| EBIT | -29.87M |
| Earnings Per Share (EPS) | -0.95 |
Full Income StatementBalance Sheet
The company has 8.56M in cash and 1.87M in
debt, giving a net cash position of 6.7M.
| Cash & Cash Equivalents | 8.56M |
| Total Debt | 1.87M |
| Net Cash | 6.7M |
| Retained Earnings | -251.39M |
| Total Assets | 34.72M |
| Working Capital | 24.64M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -21.23M
and capital expenditures -381K, giving a free cash flow of -21.61M.
| Operating Cash Flow | -21.23M |
| Capital Expenditures | -381K |
| Free Cash Flow | -21.61M |
| FCF Per Share | -0.69 |
Full Cash Flow StatementMargins
Gross margin is 100%, with operating and profit margins of -396200% and -373362.5%.
| Gross Margin | 100% |
| Operating Margin | -396200% |
| Pretax Margin | -373362.5% |
| Profit Margin | -373362.5% |
| EBITDA Margin | -362075% |
| EBIT Margin | -396200% |
| FCF Margin | -270112.5% |
